Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid

Biomed Pharmacother. 1989;43(2):121-6. doi: 10.1016/0753-3322(89)90140-6.

Abstract

The pharmacokinetics of nonsteroidal anti-inflammatory drugs (NSAIDs) in the cerebrospinal fluid (CSF) is of clinical interest as it may be related to some of their properties and side-effects. Two types of NSAIDs can be described with respect to their concentration and time course in CSF: in the first type, the transfer across the blood-brain barrier seems to be controlled by simple physico-chemical factors. These drugs (oxyphenbutazone, indomethacin, ketoprofen) are characterized by a high lipophilicity. At steady state, their free plasma concentrations correspond to their CSF concentrations. The second group consists of more hydrophilic compounds (salicylates); there is no correlation between plasma concentrations and CSF concentration. Further investigation needs to be carried out on CNS side-effects and the antialgesic activity of salicylates in relation on their CSF distribution.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / cerebrospinal fluid*
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics
  • Humans

Substances

  • Anti-Inflammatory Agents, Non-Steroidal